W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Promote life sciences community and communicate economic and health benefits of this industry. Monitor legislation related to Patent Reform. FDA Reform Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Health Issues HCR
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Promote life sciences community and communicate economic and health benefits of this industry. Monitor legislation related to Patent Reform. FDA Reform Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Food Industry (safety, labeling, etc.) FOO
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Promote life sciences community and communicate economic and health benefits of this industry. Monitor legislation related to Patent Reform. FDA Reform Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.